Evidence map›Paper›PMID 35736880›Full record

Observational studyTomography (Ann Arbor, Mich.)2022

Reclassification of Heart Failure with Preserved Ejection Fraction Following Cardiac Sympathetic Nervous System Activation: A New Cutoff Value of 58.

Toshihiko Goto, Takafumi Nakayama, Junki Yamamoto, Kento Mori, Yasuhiro Shintani, Shohei Kikuchi, Hiroshi Fujita, Hidekatsu Fukuta, Yoshihiro Seo

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Tomography (Ann Arbor, Mich.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Toshihiko GotoDepartment of Cardiology, Nagoya City University Graduate School of Medical Sciences, Nagoya 467-8601, Japan.ORCID 0000-0001-7132-2806
Takafumi NakayamaDepartment of Cardiovascular Medicine, Nagoya City University West Medical Center, Nagoya 462-8508, Japan.
Junki YamamotoDepartment of Cardiology, Nagoya City University Graduate School of Medical Sciences, Nagoya 467-8601, Japan.
Kento MoriDepartment of Cardiology, Nagoya City University Graduate School of Medical Sciences, Nagoya 467-8601, Japan.
Yasuhiro ShintaniDepartment of Cardiology, Nagoya City University Graduate School of Medical Sciences, Nagoya 467-8601, Japan.
Shohei KikuchiDepartment of Cardiology, Nagoya City University Graduate School of Medical Sciences, Nagoya 467-8601, Japan.
Hiroshi FujitaDepartment of Cardiology, Nagoya City University Graduate School of Medical Sciences, Nagoya 467-8601, Japan.
Hidekatsu FukutaClinical Research Management Center, Nagoya City University Hospital, Nagoya 467-8601, Japan.
Yoshihiro SeoDepartment of Cardiology, Nagoya City University Graduate School of Medical Sciences, Nagoya 467-8601, Japan.ORCID 0000-0003-4319-3124
Nagoya City University · JPNagoya City University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heart failure (HF) with preserved left ventricular ejection fraction (LVEF) is a heterogeneous syndrome. An LVEF of 50% is widely used to categorize patients with HF; however, this is controversial. Previously, we have reported that patients with an LVEF of ≥ 58% have good prognoses. Further, cardiac sympathetic nervous system (SNS) activation is a feature of HF. In this retrospective, observational study, the cardiac SNS activity of HF patients (n = 63, age: 78.4 ± 9.6 years; male 49.2%) with LVEF ≥ 58% (n = 15) and LVEF < 58% (n = 48) were compared using 123I-metaiodobenzylguanidine scintigraphy. During the follow-up period (median, 3.0 years), 18 all-cause deaths occurred. The delayed heart/mediastinum (H/M) ratio was significantly higher in the LVEF ≥ 58% group than in the LVEF < 58% group (2.1 ± 0.3 vs. 1.7 ± 0.4, p = 0.004), and all-cause mortality was significantly lower in patients in the former than those in the latter group (log-rank, p = 0.04). However, when these patients were divided into LVEF ≥ 50% (n = 22) and LVEF < 50% (n = 41) groups, no significant differences were found in the delayed H/M ratio, and the all-cause mortality did not differ between the groups (log-rank, p = 0.09). In conclusion, an LVEF of 58% is suitable for reclassifying patients with HF according to cardiac SNS activity.

Indexed as

Heart FailureVentricular Function, LeftAgedAged, 80 and overHumansMaleRetrospective StudiesStroke VolumeSympathetic Nervous Systemcardiac sympathetic nervous systemheart failureleft ventricular ejection fractionmetaiodobenzylguanidinemortality

Identifiers

PMID35736880
PMCPMC9229723
OpenAlexW4283167709

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.